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Background
CD85j is a receptor expressed by different cells of the
human immune system including Natural Killer (NK)
cells. Previous reports have shown that CD85j interacts
with several MHC-I molecules, as well as with some
viral proteins (Cosman D et al., 1997). We have also
demonstrated that CD85j+ NK cells efficiently control
HIV-1 replication in monocyte-derived dendritic cells
(MDDC) in vitro (Scott-Algara D et al., 2008). We
hypothesize that the CD85j+ NK cell-mediated anti-HIV
activity in MDDC is specifically dependent on the inter-
action between CD85j receptor and unknown non-HLA
class I ligand(s). Therefore we focused on the identifica-
tion CD85j ligand(s) and its(their) implication in the
control of HIV-1 infection.
Methods
To identify the CD85j ligand(s), lysates from MDDC
infected or not by HIV-1 were co-immunoprecipitated
using CD85j recombinant receptor and analyzed by
SELDI-TOF-MS protein chip arrays. The interaction
between CD85j and its ligand(s) where then confirmed
by ELISA test. Surface expression of the putative ligand
(s) was analyzed by flow cytometry. To confirm the
implication of the interaction receptor-ligand in the
control of HIV replication, NK cells were pre-stimulated
with CD85j ligands and co-cultured with HIV-infected
MDDC or CD4+ T cells, then, intracellular and superna-
tant p24 were measured.
Results
We found that the CD85j receptor interacts with the cal-
cium-binding protein S100A9. We further demonstrated
that HIV-1 infection of MDDC modulates the expression
of S100 proteins at the surface of MDDC. Pre-stimulation
of NK cells with S100A9 monomers resulted in an
increased control of HIV infection in MDDC and CD4+
T cells. Moreover, pre-stimulation of NK cells with
S100A9 tetramers resulted in a better and increased con-
trol of HIV-1 infection in CD4+ T cells.
Conclusion
Triggering the inhibitory receptor CD85j on NK cells by
S100A9 may be implicated in the establishment and/or
the regulation of the specific anti-HIV-1 NK cell response.
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